Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.67USD
3:59pm EST
Change (% chg)

$0.14 (+8.77%)
Prev Close
$1.54
Open
$1.55
Day's High
$1.68
Day's Low
$1.54
Volume
180,095
Avg. Vol
114,719
52-wk High
$3.78
52-wk Low
$1.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.12 0.25 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.22 -0.20 -0.24 --
Quarter Ending Jun-18 2 -0.25 -0.23 -0.26 --
Year Ending Dec-18 3 -1.06 -1.00 -1.17 -2.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.80 34.75
P/E High - Last 5 Yrs. -- 284.12 46.00
P/E Low - Last 5 Yrs. -- 92.89 24.22
Beta -- 0.81 0.81
Price to Sales (TTM) 142.19 135.24 8.23
Price to Book (MRQ) 2.25 20.37 5.26
Price to Tangible Book (MRQ) 2.27 28.60 6.43
Price to Cash Flow (TTM) -- 126.27 26.16
% Owned Institutions 40.10 11.97 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.02
Dividend 5 Year Growth Rate -- 1.92 5.22
Payout Ratio(TTM) -- 8.39 43.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 63.69 9.79
Sales (TTM) vs TTM 1 Yr. Ago -- 63.80 7.60
Sales - 5 Yr. Growth Rate -- 33.26 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 42.70 -99.96 17.74
EPS (TTM) vs TTM 1 Yr. Ago 36.90 -- --
EPS - 5 Yr. Growth Rate -- 46.90 11.61
Capital Spending - 5 Yr. Growth Rate -- 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.43
Current Ratio (MRQ) 3.02 5.76 3.39
LT Debt to Equity (MRQ) 0.00 16.49 12.05
Total Debt to Equity (MRQ) 21.05 18.61 15.44
Interest Coverage (TTM) -48.42 -166.79 38.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.28 54.71
Gross Margin - 5 Yr. Avg. -- 55.52 52.58
EBITD Margin (TTM) -11,976.00 -- --
EBITD - 5 Yr. Avg -- -236.98 14.67
Operating Margin (TTM) -12,122.00 -474.87 4.61
Operating Margin - 5 Yr. Avg. -- -253.74 9.99
Pre-Tax Margin (TTM) -12,258.00 -449.94 5.35
Pre-Tax Margin - 5 Yr. Avg. -- -260.30 10.27
Net Profit Margin (TTM) -12,258.00 -445.34 1.86
Net Profit Margin - 5 Yr. Avg. -- -263.73 6.57
Effective Tax Rate (TTM) -- 0.42 21.98
Effective Tax Rate - 5 Yr. Avg. -- 18.01 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,579 23,891,213 828,235,197
Net Income/Employee (TTM) -806,447 -630,600 96,880,046
Receivable Turnover (TTM) -- 14.32 5.42
Inventory Turnover (TTM) -- 2.43 3.50
Asset Turnover (TTM) 0.01 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -84.83 -1.01 10.70
Return on Assets - 5 Yr. Avg. -- -0.24 12.05
Return on Investment (TTM) -109.15 -0.65 13.63
Return on Investment - 5 Yr. Avg. -- 2.39 15.78
Return on Equity (TTM) -116.70 -3.21 15.25
Return on Equity - 5 Yr. Avg. -- -1.55 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -4.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.10%
# of Holders: 31
Total Shares Held: 9,255,491
3 Mo. Net Change: 658,880
# New Positions: 6
# Closed Positions: 6
# Increased Positions: 18
# Reduced Positions: 8
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.